|
業務類別
|
Biotechnology |
|
業務概覽
|
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others. |
| 公司地址
| 4350 Executive Drive, Suite 325, San Diego, CA, USA, 92121 |
| 電話號碼
| +1 403 670-7377 |
| 傳真號碼
| +1 403 283-0858 |
| 公司網頁
| https://www.oncolyticsbiotech.com |
| 員工數量
| 29 |
| Mr. Kirk J. Look |
Chief Financial Officer |
加元 597.48K |
30/03/2026 |
| Ms. Allison Hagerman, P. Eng. |
Chief Technology Officer |
加元 422.62K |
30/03/2026 |
| Dr. Thomas Charles Heineman, M.D. |
Chief Medical Officer |
加元 749.71K |
30/03/2026 |
| Mr. Andrew Aromando |
Chief Business Officer |
-- |
30/03/2026 |
| Ms. Amy G. Levin |
Vice President, Clinical Operations |
加元 474.26K |
07/03/2025 |
| Mr. Christophe Degois |
Vice President, Business Development |
-- |
07/03/2025 |
| Mr. Jared Kelly |
Chief Executive Officer and Director |
-- |
30/03/2026 |
| Mr. John McAdory |
Chief Operating Officer |
-- |
02/06/2026 |
|
|
| Mr. Jonathan M. Rigby |
Independent Director |
30/03/2026 |
| Ms. Patricia S. Andrews |
Director |
30/03/2026 |
| Mr. Wayne Pisano |
Chairman of the Board |
30/03/2026 |
| Mr. James T. Parsons |
Independent Director |
30/03/2026 |
| Dr. Bernd R. Seizinger, M.D.,PhD |
Independent Director |
30/03/2026 |
| Mr. Stephen C. Glover |
Independent Director |
02/06/2026 |
| Ms. Angela Holtham |
Independent Director |
30/03/2026 |
| Ms. Deborah Margaret Brown |
Independent Director |
30/03/2026 |
| Mr. Jared Kelly |
Chief Executive Officer and Director |
30/03/2026 |
|
|
|
|
